Literature DB >> 17592502

State dependent dissociation of HERG channel inhibitors.

D Stork1, E N Timin, S Berjukow, C Huber, A Hohaus, M Auer, S Hering.   

Abstract

BACKGROUND AND
PURPOSE: Inhibition of HERG channels prolongs the ventricular action potential and the QT interval with the risk of torsade de pointes arrhythmias and sudden cardiac death. Many drugs induce greater inhibition of HERG channels when the cell membrane is depolarized frequently. The dependence of inhibition on the pulsing rate may yield different IC(50) values at different frequencies and thus affect the quantification of HERG channel block. We systematically compared the kinetics of HERG channel inhibition and recovery from block by 8 blockers at different frequencies. EXPERIMENTAL APPROACH: HERG channels were expressed heterologously in Xenopus oocytes and currents were measured with the two-electrode voltage clamp technique. KEY
RESULTS: Frequency-dependent block was observed for amiodarone, cisapride, droperidol and haloperidol (group 1) whereas bepridil, domperidone, E-4031 and terfenadine (group 2) induced similar pulse-dependent block at all frequencies. With the group 1 compounds, HERG channels recovered from block in the presence of drug (recovery being voltage-dependent). No substantial recovery from block was observed with the second group of compounds. Washing out of bepridil, domperidone, E-4031 and terfenadine was substantially augmented by frequent pulsing. Mutation D540K in the HERG channel (which exhibits reopening at negative voltages) facilitated recovery from block by these compounds at -140 mV. CONCLUSION AND IMPLICATIONS: Drug molecules dissociate at different rates from open and closed HERG channels ('use-dependent' dissociation). Our data suggest that apparently 'trapped' drugs (group 2) dissociated from the open channel state whereas group 1 compounds dissociated from open and resting states.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17592502      PMCID: PMC2189824          DOI: 10.1038/sj.bjp.0707356

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

Review 1.  HERG K+ channels: friend and foe.

Authors:  J I Vandenberg; B D Walker; T J Campbell
Journal:  Trends Pharmacol Sci       Date:  2001-05       Impact factor: 14.819

Review 2.  Understanding the structure-activity relationship of the human ether-a-go-go-related gene cardiac K+ channel. A model for bad behavior.

Authors:  Robert Pearlstein; Roy Vaz; David Rampe
Journal:  J Med Chem       Date:  2003-05-22       Impact factor: 7.446

3.  Comparison of kinetic properties of quinidine and dofetilide block of HERG channels.

Authors:  Kenji Tsujimae; Shingo Suzuki; Mitsuhiko Yamada; Yoshihisa Kurachi
Journal:  Eur J Pharmacol       Date:  2004-06-16       Impact factor: 4.432

4.  Variability in the measurement of hERG potassium channel inhibition: effects of temperature and stimulus pattern.

Authors:  Glenn E Kirsch; Elena S Trepakova; Jessica C Brimecombe; Serguei S Sidach; Hope D Erickson; Mary C Kochan; Lisa M Shyjka; Antonio E Lacerda; Arthur M Brown
Journal:  J Pharmacol Toxicol Methods       Date:  2004 Sep-Oct       Impact factor: 1.950

5.  Blockade of the HERG human cardiac K(+) channel by the antidepressant drug amitriptyline.

Authors:  S H Jo; J B Youm; C O Lee; Y E Earm; W K Ho
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

Review 6.  Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development.

Authors:  W S Redfern; L Carlsson; A S Davis; W G Lynch; I MacKenzie; S Palethorpe; P K S Siegl; I Strang; A T Sullivan; R Wallis; A J Camm; T G Hammond
Journal:  Cardiovasc Res       Date:  2003-04-01       Impact factor: 10.787

7.  A structural basis for drug-induced long QT syndrome.

Authors:  J S Mitcheson; J Chen; M Lin; C Culberson; M C Sanguinetti
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

Review 8.  I(Kr): the hERG channel.

Authors:  G N Tseng
Journal:  J Mol Cell Cardiol       Date:  2001-05       Impact factor: 5.000

9.  Dissociation of E-4031 from the HERG channel caused by mutations of an amino acid results in greater block at high stimulation frequency.

Authors:  Kuniaki Ishii; Mirei Nagai; Masahiro Takahashi; Masao Endoh
Journal:  Cardiovasc Res       Date:  2003-03       Impact factor: 10.787

Review 10.  The impact of drug-induced QT interval prolongation on drug discovery and development.

Authors:  Bernard Fermini; Anthony A Fossa
Journal:  Nat Rev Drug Discov       Date:  2003-06       Impact factor: 84.694

View more
  36 in total

Review 1.  Revealing the structural basis of action of hERG potassium channel activators and blockers.

Authors:  Matthew Perry; Michael Sanguinetti; John Mitcheson
Journal:  J Physiol       Date:  2010-07-19       Impact factor: 5.182

2.  Inhibition of cloned hERG potassium channels by risperidone and paliperidone.

Authors:  Hong Joon Lee; Jin-Sung Choi; Bok Hee Choi; Sang June Hahn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-03-06       Impact factor: 3.000

Review 3.  Modification of K+ channel-drug interactions by ancillary subunits.

Authors:  Glenna C L Bett; Randall L Rasmusson
Journal:  J Physiol       Date:  2007-12-20       Impact factor: 5.182

4.  Kv 11.1 (hERG)-induced cardiotoxicity: a molecular insight from a binding kinetics study of prototypical Kv 11.1 (hERG) inhibitors.

Authors:  Z Yu; A P IJzerman; L H Heitman
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

5.  Late sodium current contributes to the reverse rate-dependent effect of IKr inhibition on ventricular repolarization.

Authors:  Lin Wu; Jihua Ma; Hong Li; Chao Wang; Eleonora Grandi; Peihua Zhang; Antao Luo; Donald M Bers; John C Shryock; Luiz Belardinelli
Journal:  Circulation       Date:  2011-04-11       Impact factor: 29.690

Review 6.  Computational membrane biophysics: From ion channel interactions with drugs to cellular function.

Authors:  Williams E Miranda; Van A Ngo; Laura L Perissinotti; Sergei Yu Noskov
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2017-08-26       Impact factor: 3.036

7.  Role of the activation gate in determining the extracellular potassium dependency of block of HERG by trapped drugs.

Authors:  Kristeen Pareja; Elaine Chu; Katrina Dodyk; Kristofer Richter; Alan Miller
Journal:  Channels (Austin)       Date:  2012-12-06       Impact factor: 2.581

8.  Molecular determinants of hERG channel block by terfenadine and cisapride.

Authors:  Kaichiro Kamiya; Ryoko Niwa; Mikio Morishima; Haruo Honjo; Michael C Sanguinetti
Journal:  J Pharmacol Sci       Date:  2008-11-06       Impact factor: 3.337

9.  Predicting new molecular targets for known drugs.

Authors:  Michael J Keiser; Vincent Setola; John J Irwin; Christian Laggner; Atheir I Abbas; Sandra J Hufeisen; Niels H Jensen; Michael B Kuijer; Roberto C Matos; Thuy B Tran; Ryan Whaley; Richard A Glennon; Jérôme Hert; Kelan L H Thomas; Douglas D Edwards; Brian K Shoichet; Bryan L Roth
Journal:  Nature       Date:  2009-11-01       Impact factor: 49.962

10.  Mechanism of HERG potassium channel inhibition by tetra-n-octylammonium bromide and benzethonium chloride.

Authors:  Yan Long; Zuoxian Lin; Menghang Xia; Wei Zheng; Zhiyuan Li
Journal:  Toxicol Appl Pharmacol       Date:  2013-01-08       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.